以下文章来源于健闻咨询 ，作者健闻商业 四十不惑，飞利浦正以本土化为根基，以创新为引擎，开启一场"与华同新"的崭新征程。 从医院到家庭，全场景构建健康服务闭环 "我们希望将更好的健康成效惠及更多人。"这是飞利浦"创新于心，关怀众享"(Better Care for More People)愿景的核心。面对中国医疗体系的多元结构与大众健康需求的持续升级，飞利浦的每一项技术 突破，都承载着技术突破与人群覆盖的双重使命。 健闻咨询 . 医疗行业跨界洞察 提及飞利浦，许多人或许还会联想到那个"明亮的"老友。而在中国深耕的四十年，飞利浦早已完成了一 场蜕变，全心奔赴全新的使命：守护生命健康。 在刚刚闭幕的第八届中国国际进口博览会上，飞利浦以"创新于心，关怀众享"（Better Care for More People）为展台主线，携近50款创新产品与解决方案亮相，其中十大"中国首展"新品、十余款AI赋能产 品，覆盖"健康生活、疾病预防、精准诊断、介入治疗、家庭护理"的健康关护全程。 飞利浦进博会展台 "四十周年是非常有纪念意义的时间，也证明了飞利浦在中国健康行业的持续投入。"飞利浦大中华区副 总裁、市场部负责人杨冬岚接 ...

提及飞利浦，许多人或许还会联想到那个"明亮的"老友。而在中国深耕的四十年，飞利浦早已完成了一 场蜕变，全心奔赴全新的使命：守护生命健康。 在刚刚闭幕的第八届中国国际进口博览会上，飞利浦以"创新于心，关怀众享"（Better Care for More People）为展台主线，携近50款创新产品与解决方案亮相，其中十大"中国首展"新品、十余款AI赋能产 品，覆盖"健康生活、疾病预防、精准诊断、介入治疗、家庭护理"的健康关护全程。 飞利浦进博会展台 "四十周年是非常有纪念意义的时间，也证明了飞利浦在中国健康行业的持续投入。"飞利浦大中华区副 总裁、市场部负责人杨冬岚接受健闻咨询采访时表示。从1985年在华成立首家合资企业至今，飞利浦亲 历并参与了中国健康产业的崛起之路。如今，中国已成为其全球第二大市场，五大创新中心与五大生产 基地构筑起"本土研发制造"的闭环体系。 四十不惑，飞利浦正以本土化为根基，以创新为引擎，开启一场"与华同新"的崭新征程。 举例来说，在院内诊疗领域，今年的重磅展品MR7700多核磁共振系统，上个月底刚拿到中国NMPA注 册证，便马不停蹄亮相进博会。这款3T临床多核磁共振设备可提供无辐射、无 ...

Core Viewpoint - The 8th China International Import Expo highlights Philips' commitment to innovation in healthcare, showcasing nearly 50 innovative products and ten new launches in China, emphasizing the company's strategic focus on the Chinese market and the integration of AI in healthcare solutions [1][2][3]. Group 1: Philips' Strategy in China - Philips aims to create a "closed-loop local business" model in China, balancing local innovation with global needs, particularly in the context of AI and healthcare [1][2]. - The company recognizes the forward-thinking innovation proposed by Chinese clinical experts, which is driven by the unique healthcare challenges and policies in China [2]. Group 2: Product Innovations - Philips introduced the MR 7700, the first 3T MRI device in the industry with multi-nuclear clinical capabilities, enabling non-invasive biochemical metabolic mapping to better understand disease pathways [3]. - The Spectral CT 7600, developed by Philips' Shenyang R&D team, enhances clinical energy scanning capabilities without increasing radiation exposure, catering to various patient needs [8][9]. Group 3: AI Integration in Healthcare - AI is viewed as a core driver for reshaping the future of healthcare in China, with a high acceptance rate among healthcare professionals and patients [4][5]. - Philips emphasizes the importance of seamless integration of AI into workflows, ensuring that healthcare professionals can focus on patient care without needing extensive training on AI technologies [6][7]. Group 4: Commitment to Local Development - Philips has established a comprehensive R&D capability in China, covering the entire product lifecycle from development to market [9]. - The company is transitioning from being a mere medical device supplier to a co-creator in the Chinese healthcare ecosystem, aiming to leverage local innovations for global benefits [9].